SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (265)2/21/2003 11:57:13 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 824
 
<<I heard the same, but was corrected---they said that in in November at AHA they announced they were 2/3 way through.>>

Yes, I think that this is correct. So, note in WSJ that enrollment will be completed by mid-year is wrong, or it did slow down. Usually, second half enrollment is faster, if there is interest in drug (and after initial experience).

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News